An ASM participant must have evidence of processes, workflows, or technology that require the ASM participant to do all of the following: (i) Confirm the ASM beneficiary has access to primary care services and, if not, assist the ASM beneficiary in finding a clinician who provides primary care services
The Phase 2 trial results Published in the New England Journal of Medicine, the Phase 2 trial showed that participants receiving the highest dose of retatrutide (12mg weekly) achieved a mean weight reduction of 24.2% at 48 weeks
10.1111/j.1365-2710.2004.00626.x
A strong, unusual, or foul odor suggests bacterial contamination
Kang SS, Wong PWK, and Malinow MR (1992)
N-acetylcysteine (NAC) The three amino acids that form glutathione do so in two steps